KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for Charles River Laboratories International (CRL) over the last 15 years, with Q3 2025 value amounting to $44.8 million.

  • Charles River Laboratories International's Depreciation and Depletion fell 762.89% to $44.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $180.9 million, marking a year-over-year decrease of 392.99%. This contributed to the annual value of $190.2 million for FY2024, which is 764.01% up from last year.
  • Latest data reveals that Charles River Laboratories International reported Depreciation and Depletion of $44.8 million as of Q3 2025, which was down 762.89% from $44.3 million recorded in Q2 2025.
  • Over the past 5 years, Charles River Laboratories International's Depreciation and Depletion peaked at $155.6 million during Q4 2022, and registered a low of $559000.0 during Q1 2022.
  • Its 5-year average for Depreciation and Depletion is $42.0 million, with a median of $44.3 million in 2025.
  • Over the last 5 years, Charles River Laboratories International's Depreciation and Depletion had its largest YoY gain of 787853.31% in 2023, and its largest YoY loss of 7011.86% in 2023.
  • Quarter analysis of 5 years shows Charles River Laboratories International's Depreciation and Depletion stood at $138.6 million in 2021, then rose by 12.28% to $155.6 million in 2022, then plummeted by 70.12% to $46.5 million in 2023, then rose by 4.09% to $48.4 million in 2024, then dropped by 7.44% to $44.8 million in 2025.
  • Its last three reported values are $44.8 million in Q3 2025, $44.3 million for Q2 2025, and $43.4 million during Q1 2025.